Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zinc finger proteins (ZFPs) in health and disease. | Mol Biomed | 2026 | 41772312 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Prognostic Relevance of ACSL4 as a Serological Marker and Its Mediating Roles in Acute Supratentorial Intracerebral Hemorrhage: An Observational Analytical Study. | Int J Gen Med | 2026 | 41769051 | PubTator, text mining | PubMed |
| Efficacy and safety of Jinlida granules as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2026 | 41767388 | PubTator, text mining | PubMed |
| ALDH1L2 induces resistance to chemotherapy in small cell lung cancer by inhibiting ferroptosis. | Redox Biol | 2026 | 41764940 | PubTator, text mining | PubMed |
| Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms. | Biochim Biophys Acta Rev Cancer | 2026 | 41763496 | PubTator, text mining | PubMed |
| Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1. | Phytomedicine | 2026 | 41759426 | PubTator, text mining | PubMed |
| HIF1A transcriptionally activates CDKN1A to drive ferroptosis in skeletal muscle ischaemia-reperfusion injury. | J Orthop Translat | 2026 | 41757293 | PubTator, text mining | PubMed |
| Yizong Tongluo formula attenuates idiopathic pulmonary fibrosis and inflammatory injury by inhibiting HIF-1α/LSH/SCD1-mediated ferroptosis. | Front Immunol | 2026 | 41756284 | PubTator, text mining | PubMed |
| Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | 41754792 | PubTator, text mining | PubMed |
| Micro- and Nanoplastics and Human Health: Role of Food Nutrients Targeting Nfe2l2 Gene in Diabetes. | Nutrients | 2026 | 41754117 | PubTator, text mining | PubMed |
| From Exposure to Atherosclerosis: Mechanistic Insights into Phthalate-Driven Ischemic Heart Disease and Prevention Strategies. | Life (Basel) | 2026 | 41752962 | PubTator, text mining | PubMed |
| Exercise-Induced Irisin: A Novel Strategy for Neuroinflammation Alleviation and Neurorepair in Diabetic Retinopathy. | Int J Mol Sci | 2026 | 41751986 | PubTator, text mining | PubMed |
| Molecular Mechanisms, Dynamic Lesions, and Therapeutic Targets in Intestinal Ischemia-Reperfusion Injury: A Systematic Review. | Int J Mol Sci | 2026 | 41751903 | PubTator, text mining | PubMed |
| Exosome-Mediated Intercellular Communication in the Pathological Processes of Gouty Arthritis and Its Treatment. | Int J Mol Sci | 2026 | 41751795 | PubTator, text mining | PubMed |
| Gender-Specific Gene Regulation of Ferroptosis in Non-Utilized Liver Donors. | Genes (Basel) | 2026 | 41751603 | PubTator, text mining | PubMed |
| Cucurbitacin B Inhibits Hepatocellular Carcinoma by Inducing Ferroptosis and Activating the cGAS-STING Pathway. | Curr Issues Mol Biol | 2026 | 41751402 | PubTator, text mining | PubMed |
| Potential Involvement of Ferroptosis in Duchenne Muscular Dystrophy-Associated Cardiomyopathy. | Biomedicines | 2026 | 41751371 | PubTator, text mining | PubMed |
| Artificial Intelligence Drives Advances in Multi-Omics Analysis and Precision Medicine for Sepsis. | Biomedicines | 2026 | 41751160 | PubTator, text mining | PubMed |
| Inducing Ferroptosis: Sensitization Strategy for Radiotherapy and Its Application. | Antioxidants (Basel) | 2026 | 41750617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=18